23andme will appeal to more and more masses as genetics becomes core part of health care, says ceo
Published 2 years ago • 1.9K plays • Length 4:00Download video MP4
Download video MP3
Similar videos
-
10:00
23andme ceo: empowering health | mad money | cnbc
-
3:01
23andme faces nasdaq delisting after its entire board resigns
-
7:40
23andme ceo set to take on sales slump | dna testing: the promise and the peril
-
7:05
23andme ceo on coronavirus genetic test
-
32:05
23andme ceo talks privacy, personalized medicine, and how genetics can help predict disease
-
9:40
23andme's board quits en masse – what really happened? | deep dive podcast
-
4:30
joe rogan - the problem with 23andme
-
57:09
anne wojcicki, co-founder and ceo of 23andme
-
5:07
health is the ultimate driver of her company's long-term growth: 23andme ceo
-
5:05
23andme founder on the future of health care
-
17:01
ceo of 23andme on disrupting the healthcare industry | j.p. morgan
-
6:25
23andme ceo wojcicki: we are part of the problem
-
4:27
23andme faces nasdaq delisting
-
4:13
23andme ceo on deal to buy lemonaid: i love lemonaid for the pharmacy component
-
0:47
do you trust 23andme?
-
6:18
harnessing the code of life with 23andme ceo anne wojcicki at evolve global summit 2023
-
7:22
23andme ceo is happy to be done with spac process
-
10:15
why the human genome could be health care’s holy grail
-
0:23
why asians should never buy 23andme
-
2:31
healthcare is still ‘stuck in a world of white coats’: 23andme ceo
-
5:10
answering patient questions about direct-to-consumer genetic testing (23andme)
-
5:41
23andme ceo talks growth, drug development, and the future of health care